Surgery – Instruments – Electrical application
Reexamination Certificate
2006-02-07
2006-02-07
Peffley, Michael (Department: 3739)
Surgery
Instruments
Electrical application
C607S101000
Reexamination Certificate
active
06994706
ABSTRACT:
An apparatus and a method for treatment of benign prostatic hyperplasia are disclosed. The apparatus includes an applicator piece carrying a set of electrodes shaped and positioned to create a substantial electric field in the volume of hyperplasia and a pulse generator adapted for delivery of electrical pulses above the upper electroporation limit for the neoplastic cells. The amplitude, duration and number of the electrical pulses are generally selected to cause necrosis of a significant fraction of the volume of benign prostatic hyperplasia. The apparatus may include a high frequency system for heating the prostatic tissue and a cooling system for cooling the urethra. The combined action of heating and cooling may increase the temperature of the prostate cells to 45° C. to 55° C., while keeping the urinary tract at a temperature 15° C. to 20° C. This temperature distribution can increase the selectivity of the treatment by increasing susceptibility of the neoplastic cells to the electroporation treatment and decreasing it for the normal urethral tissues.
REFERENCES:
patent: 5403311 (1995-04-01), Abele et al.
patent: 5536240 (1996-07-01), Edwards et al.
patent: 5800378 (1998-09-01), Edwards et al.
patent: 5843026 (1998-12-01), Edwards et al.
patent: 6009347 (1999-12-01), Hofmann
patent: 6016452 (2000-01-01), Kasevich
patent: 6106521 (2000-08-01), Blewett et al.
patent: 6208893 (2001-03-01), Hofmann
patent: 6241702 (2001-06-01), Lundquist et al.
patent: 6692493 (2004-02-01), McGovern et al.
patent: 2002/0002393 (2002-01-01), Mitchell
patent: 2004/0133194 (2004-07-01), Eum et al.
Urology Times, The Leading Newsmagazine for Urologists, May 2001, vol. 29, Supplement 1.
BJU International (1999), 84, 1035-1037, To determine whether the temperature of 2% lignocaine gel affects the initial discomfort which may be associated with its instillation into the male urethra.
The TUNA Procedure for BPH: Review of the Technology; The TUNA Procedure for BPH: Basic Procedure and Clinical Results, Reprinted fromn Infections in Urology, Jul./Aug. 1998 and Sep./Oct. 1998.
TUNA—Suggested Local Anesthesia Guidelines.
1204, Long-Term Evaluation of Transurethral Needle Ablation of the Prostate (TUNA) for Treatment of Benign Prostatic Hyperplasia (BPH): Clinical Outcome After 5 Years, Presented at 2001 AUA National Meeting, Anaheim, CA—Jun. 05, 2001.
Highlights From Worldwide Clinical Studies, Transurethral Needle Ablation (TUNA), Vidamed's Office TUNA System.
LIFESTYLE, Good News for Boomers, Newsweek Dec. 30, 1996/Jan. 6, 1997.
Urology, vol. 50, No. 2, Aug. 1997, Transurethral Needle Ablation of the Prostate, Michael J. Naslund.
It's About the Need, 50% of all men over Age 50, 80% of all men over ago 80 exhibit some or all of the symptoms of Benign Prostatic Hyperplasia (BPH), Precision Office TUNA System.
Possible Mechanisms of Action of Transurethral Needle Ablation of the Prostate on Benign Prostatic Hyperplasia Symptoms: A Neurohistochemical Study, Alexandre R. Zlotta, Gil Raviv, Marie-Odile Peny, Jean-Christophe Noel, Jules Haot and Claude C. Schluman, Reprinted from Journal of Urology, vol. 157 No. 3, Mar. 1997, pp. 894-899.
Chornenky Victor
Jaafar Ali
Gregersen Craig
Minnesota Medical Physics LLC
Peffley Michael
LandOfFree
Apparatus and method for treatment of benign prostatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and method for treatment of benign prostatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and method for treatment of benign prostatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3691615